Price $12.07 |
Market Cap
395.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
76.0
|
P/B
6.76
|
P/S
3.84
|
Dividend %
-
|
|
P/CF
25.7
|
P/FCF
-
|
Op. Cash Flow
-6.7K
|
FCF
-0.2
|
|
Op. Margin
6.20%
|
Net Margin
5.20%
|
ROE
9.30%
|
ROI
15.90%
|
|
ROA
7.20%
|
EPS Growth
-54.80%
|
Current Ratio
6.2
|
Debt/Equity
0.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co (BMY) | $58.36 | - | 3.30% | 131.48B | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $2.88 | - | - | 105.2M | Strong Buy |
| Pieris Pharmaceuticals Inc (PIRS) | $4.51 | - | - | 344.9M | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.38 | - | - | 620.2M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.85 | - | - | 95.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
